# Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

> **NCT00003060** · PHASE1 · TERMINATED · sponsor: **Louisiana State University Health Sciences Center Shreveport** · enrollment: 6 (estimated)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** methotrexate
- **PROCEDURE:** allogeneic bone marrow transplantation

## Key facts

- **NCT ID:** NCT00003060
- **Lead sponsor:** Louisiana State University Health Sciences Center Shreveport
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1995-03
- **Primary completion:** 2001-02-22
- **Final completion:** 2001-02-22
- **Target enrollment:** 6 (ESTIMATED)
- **Why stopped:** lack of patient accrual
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003060, "Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00003060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*